Literature DB >> 22190997

Characterization of Single-Nucleotide Polymorphisms in the Tumor Necrosis Factor α Promoter Region and in Lymphotoxin α in Squamous Intraepithelial Lesions, Precursors of Cervical Cancer.

Miriam Enriqueta Nieves-Ramirez1, Oswaldo Partida-Rodriguez, Pedro Eduardo Alegre-Crespo, Maria Del Carmen Tapia-Lugo, Martha Esthela Perez-Rodriguez.   

Abstract

Development of cervical cancer is a long process of abnormal cancerous cell growth in the cervix and is primarily the result of infection with specific high-risk types of human papillomavirus (HPV). The cytokines tumor necrosis factor α (TNFα) and lymphotoxin α (LTA) have an important role in all stages of cervical cancer and have the ability to induce the regression or promote the development of human tumors. Biologically important single-nucleotide polymorphisms (SNPs) occur within the TNFα and LTA genes. Therefore, the purpose of this study was to investigate the SNPs in the TNFα promoter region (-163, -238, -244, -308, -376, -857, -863, and -1031) and in the first intron of LTA (+252) in women with precursor lesions of cervical cancer. Overall, we studied 396 women from Mexico City. A total of 191 patients with HPV infection and precursor cervical lesions were subdivided in two groups: those with low-grade squamous intraepithelial lesions (n = 132) and those with high-grade squamous intraepithelial lesions (n = 59). Women (n = 205) negative for HPV and without cervical lesions were also included in the study. DNA was extracted from peripheral white blood cells and from cervical samples, and detection of biallelic polymorphisms of TNFα and LTA was performed using the polymerase chain reaction-sequence-specific oligonucleotide probe and restriction fragment length polymorphism techniques, respectively. We demonstrated that risk is associated with the genotype G/A (odds ratio = 2.48) and that protection is associated with the genotype G/G of SNP TNFα -376 (odds ratio = 0.37).

Entities:  

Year:  2011        PMID: 22190997      PMCID: PMC3243656          DOI: 10.1593/tlo.11226

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  58 in total

1.  Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

Authors:  I A Udalova; A Richardson; A Denys; C Smith; H Ackerman; B Foxwell; D Kwiatkowski
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

3.  TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry.

Authors:  A Baena; J Y Leung; A D Sullivan; I Landires; N Vasquez-Luna; J Quiñones-Berrocal; P A Fraser; G P Uko; J C Delgado; O P Clavijo; S Thim; S R Meshnick; T Nyirenda; E J Yunis; A E Goldfeld
Journal:  Genes Immun       Date:  2002-12       Impact factor: 2.676

4.  G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer.

Authors:  Isabel Duarte; Alexandra Santos; Hugo Sousa; Raquel Catarino; Daniela Pinto; Ana Matos; Deolinda Pereira; José Moutinho; Paulo Canedo; José Carlos Machado; Rui Medeiros
Journal:  Biochem Biophys Res Commun       Date:  2005-08-26       Impact factor: 3.575

5.  The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis.

Authors:  C P Kang; K W Lee; D H Yoo; C Kang; S C Bae
Journal:  Rheumatology (Oxford)       Date:  2005-02-03       Impact factor: 7.580

6.  Genetic polymorphisms in TNF genes and tuberculosis in North Indians.

Authors:  Shilpy Sharma; Jaishriram Rathored; Balaram Ghosh; Surendra K Sharma
Journal:  BMC Infect Dis       Date:  2010-06-10       Impact factor: 3.090

7.  TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia.

Authors:  A Kirkpatrick; J Bidwell; A J C van den Brule; C J L M Meijer; J Pawade; S Glew
Journal:  Gynecol Oncol       Date:  2004-02       Impact factor: 5.482

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Simplification of the new Bethesda 2001 classification system.

Authors:  Jonathan S Berek
Journal:  Am J Obstet Gynecol       Date:  2003-03       Impact factor: 8.661

10.  Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.

Authors:  Iman A F Azmy; Saba P Balasubramanian; Anthony G Wilson; Timothy J Stephenson; Angela Cox; Nicola J Brown; Malcolm W R Reed
Journal:  Breast Cancer Res       Date:  2004-05-24       Impact factor: 6.466

View more
  11 in total

1.  TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population.

Authors:  Andrzej Roszak; Matthew Misztal; Anna Sowińska; Paweł P Jagodziński
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

2.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

3.  Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study.

Authors:  Guadalupe Morales-García; Ramcés Falfán-Valencia; Román Alejandro García-Ramírez; Ángel Camarena; Alejandra Ramirez-Venegas; Manuel Castillejos-López; Martha Pérez-Rodríguez; César González-Bonilla; Concepción Grajales-Muñíz; Víctor Borja-Aburto; Juan Manuel Mejía-Aranguré
Journal:  BMC Infect Dis       Date:  2012-11-13       Impact factor: 3.090

4.  Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis.

Authors:  Min Li; Ying Han; Ting-Ting Wu; Yichen Feng; Hong-Bo Wang
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity.

Authors:  Aziz Khorrami; Mortaza Bonyadi; Mandana Rafeey; Omid Omrani
Journal:  Iran J Pediatr       Date:  2015-02-21       Impact factor: 0.364

Review 6.  Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.

Authors:  Yi Huang; Xi Yu; Lingyan Wang; Shengjun Zhou; Jie Sun; Nan Feng; Sheng Nie; Jingmi Wu; Feng Gao; Bing Fei; Jianyong Wang; Zhiqing Lin; Xianru Li; Leiting Xu; Xiang Gao; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

Review 7.  Tumor Necrosis Factor-α T-857C (rs1799724) Polymorphism and Risk of Cancers: A Meta-Analysis.

Authors:  Ping Wang; June Wang; Mingxia Yu; Zhiqiang Li
Journal:  Dis Markers       Date:  2016-12-27       Impact factor: 3.434

8.  Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.

Authors:  Qi Xiao; BiQi Fu; Ping Chen; Zhong Zhong Liu; Wei Wang; QiFa Ye
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

9.  Interactions between polymorphisms in the 3'untranslated region of the cyclin dependent kinase 6 gene and the human papillomavirus infection, and risk of cervical precancerous lesions.

Authors:  Xingguang Ye; Lipeng Jing; Xingming Zhong; Di Xiao; Meiling Ou; Congcong Guo; Guang Yang; Chunxia Jing; Xiangcai Wei
Journal:  Biomed Rep       Date:  2017-05-03

10.  The Correlation Between TNF-α Promoter Gene Polymorphism and Genetic Susceptibility to Cervical Cancer.

Authors:  Xiuyun Li; Geping Yin; Juan Li; Aifang Wu; Zheng Yuan; Jing Liang; Qinghua Sun
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.